will tirzepatide cause diarrhea Side Effects: What to Expect (and When to Worry) In a 37-year-old patient with

Long B, Pelletier J, Koyfman A, Bridwell RE

Incretin based therapies such as GLP-1 receptor agonists have revolutionised management of type 2 diabetes by enhancing insulin secretion, slowing gastric emptying and reducing appetite (Dungan & DeSantis, 2025)

Common side effects include nausea, vomiting, and gastric upsets such as diarrhea or constipation

5-Amino-1MQ has been investigated in preclinical research in relation to nicotinamide N-methyltransferase (NNMT) inhibition and associated cellular pathways

For other drugs such as MAO inhibitors, amantadine, and dopamine agonists, no indication was found for an effect on taxa abundance or microbial functions (Horsager et al., 2020)